Thrombolytic therapy for noncoronary diseases

Sherry, Sol

doi:10.1016/s0196-0644(05)81662-2

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1992

1996

Publication Types

Select...

Article5

Book1

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 12 publications

(1 citation statement)

References 75 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thrombolytic therapy increases lung perfusion and the oxygen exchange, in addition to improving pulmonary hypertension [21]. This therapy is recommended in cases of severe embolism and in hemodynamically compro mised patients [21], Thrombolytic therapy followed by anticoagulation has been shown to be more beneficial than anticoagulation alone [22], The best results are obtained with early treatment, as it decreases morbidity and prevents the development pulmonary hypertension.…”

Section: Discussionmentioning

confidence: 99%

Thrombolytic Therapy in Pulmonary Embolism of Behçet’s Disease

Sánchez‐Bursón

Corzo²,

Marenco³

et al. 1996

Acta Haematol

View full text Add to dashboard Cite

We report the case of a patient with Behçet’s disease who presented with deep vein thrombosis and pulmonary embolism. In spite of being treated initially with anticoagulants, corticosteroid and oral cyclophosphamide, the patient presented again with a new pulmonary embolism. This critical situation made us initiate thrombolytic therapy with a urokinase ‘bolus’ followed by continuous infusion through a catheter into the pulmonary artery. Treatment response was good and 2 years later there was no evidence of new thrombotic episodes.

show abstract

Section: Discussionmentioning

confidence: 99%